Tamezol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tamezol

What is Tamezol (Omeprazole)?

Tamezol is a medication containing the active ingredient omeprazole. It belongs to a class of drugs known as proton pump inhibitors (PPIs). These medications are primarily used to manage conditions related to the production of stomach acid.

Mechanism of Action

Omeprazole works by targeting the acid-producing cells in the lining of the stomach. It inhibits the enzyme system referred to as the proton pump, which is responsible for the final step of acid secretion. By blocking these pumps, the medication effectively reduces the total volume of acid released into the digestive tract.

Therapeutic Use

Reducing stomach acid is a common therapeutic approach for several gastrointestinal issues. When acid levels are lowered, it allows the lining of the esophagus and stomach to recover from irritation or erosion. Tamezol is typically utilized in the following contexts:

  • Acid Reflux and GERD: It helps address the backflow of stomach acid into the esophagus, which often causes a burning sensation.
  • Peptic Ulcers: It creates an environment conducive to the healing of ulcers in the stomach or the upper part of the small intestine.
  • Zollinger-Ellison Syndrome: It is used to manage rare conditions where the stomach produces excessive amounts of acid.
  • Gastric Protection: It may be used to protect the stomach lining in individuals who require long-term use of certain anti-inflammatory medications.

Characteristics

As a PPI, omeprazole is known for providing a sustained reduction in acidity rather than immediate, short-term relief. While it does not neutralize existing acid already present in the stomach, its ability to limit new acid production makes it a foundational component in the management of chronic acid-related disorders.

Regulatory References

  1. Omeprazole DailyMed Label

What side effects are possible with Tamezol?

Possible Side Effects and Safety Information

Adverse reactions associated with omeprazole are classified in regulatory documents according to frequency and the body system affected. All safety information is based strictly on governmental health authority labeling. The medication is formally contraindicated in patients with known hypersensitivity to the active substance, other substituted benzimidazoles, or any excipients.


Frequency-Classified Adverse Reactions

The safety profile is primarily characterized by the following categories:

  • Common (may affect up to 1 in 10 people): Headache, and gastrointestinal effects including abdominal pain, constipation, diarrhea, flatulence, nausea, and vomiting.
  • Uncommon (may affect up to 1 in 100 people): Insomnia, dizziness, paresthesia (pins and needles sensation), and skin reactions (dermatitis, rash, pruritus, urticaria).
  • Rare (may affect up to 1 in 1,000 people): Hypersensitivity reactions (e.g., angioedema, anaphylactic shock), changes in blood counts (leukopenia, thrombocytopenia), and acute interstitial nephritis (a kidney condition).

Serious and Duration-Related Safety Patterns

The regulatory safety structure highlights rare but serious events, such as Severe Cutaneous Adverse Reactions and hepatic failure. Furthermore, specific risks are associated with the duration of treatment, as documented in official labeling.

  • Long-term use (typically over three months) has been associated with a risk of Hypomagnesemia (low blood magnesium levels).
  • Prolonged treatment (over one year), particularly at high doses, is associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine.

Overdose and Emergency Response

The official regulatory documentation for omeprazole details the documented clinical presentation of an overdose, which is generally classified as mild to moderate. Reported signs include drowsiness, headache, blurred vision, tachycardia (rapid heart rate), nausea, vomiting, and dry mouth. Even at reported single oral doses up to 2400 mg, effects are typically reversible.

When to Seek Immediate Medical Help

Regulatory guidance explicitly mandates that immediate medical attention must be sought if severe or life-threatening symptoms occur. These emergency triggers include the onset of a seizure, collapse, or difficulty breathing (trouble breathing). In these severe instances, individuals should call emergency services immediately or contact a Poison Control Center for guidance.

Overdose Management

Management is based entirely on the patient's clinical state, as no specific antidote is known for omeprazole overdose. Treatment is restricted to symptomatic and supportive measures. Official documents state that procedures such as gastric emptying or the administration of activated charcoal may be considered. However, due to the drug's high protein binding, hemodialysis is not expected to be useful for removing omeprazole from the body.

Therapeutic Uses of Tamezol

Quick Facts

  • Condition Management: May help manage symptoms of Gastroesophageal Reflux Disease (GERD).
  • Ulcer Support: Used for the short-term treatment of active duodenal and benign gastric ulcers.
  • Esophagitis: Indicated for the healing and maintenance of healing of erosive esophagitis.
  • H. pylori: Used in combination with antibiotics for the treatment of H. pylori infection to reduce the risk of duodenal ulcer recurrence.
  • Hypersecretory Conditions: Prescribed for the long-term management of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome.

What Tamezol (Omeprazole) Treats: Main Uses and Benefits

Omeprazole is a prescribed medication used for therapeutic management of conditions that relate to excess gastric acid. This option may assist in the relief of heartburn and other symptoms associated with Gastroesophageal Reflux Disease (GERD). It is indicated for the short-term healing of active benign gastric ulcers and duodenal ulcers.

In pediatric and adult patient populations, the medication is also indicated for the short-term treatment of erosive esophagitis that is due to acid-mediated GERD, and it is used to maintain the healing of this condition. For certain individuals with duodenal ulcer disease and confirmed H. pylori infection, Omeprazole is used as part of a combination regimen with antibiotics to eradicate the bacteria and potentially reduce the chance of the ulcer returning. Furthermore, the drug is used for the long-term management of pathological hypersecretory states (e.g., Zollinger-Ellison syndrome).

Eligibility and Restrictions for Use

Who can and cannot use Tamezol (Omeprazole)?

Eligibility for Tamezol (omeprazole) is strictly governed by the population rules defined in regulatory prescribing information, setting clear boundaries for use.

Category Eligibility Status (Official Labeling)
Populations Allowed Adults and pediatric patients (starting at age 1 year for symptomatic GERD and erosive esophagitis, or 4 years for H. pylori eradication)
Contraindicated Groups Patients with known hypersensitivity to omeprazole or any substituted benzimidazole (e.g., esomeprazole, pantoprazole).
Drug-Specific Prohibition Must not be used concomitantly with certain antiretroviral drugs, such as rilpivirine-containing products.
Conditional Use Patients with severe hepatic impairment require caution and may need dose consideration. Pregnant and lactating individuals are eligible only after a formal risk-benefit assessment, as omeprazole is present in human milk.
Use Not Established Use in infants under 1 year of age is generally not recommended or not established for most indications, according to regulatory data.

These official statements define who is formally eligible for omeprazole use, creating absolute prohibitions for contraindicated groups and establishing specific age thresholds and conditions for use in other populations.

What should I know about interactions with other medicines?

Tamezol (Omeprazole) Interactions with other medicines and products

Regulatory documents classify the interaction profile of Tamezol (Omeprazole) based on its activity as a moderate inhibitor of the CYP2C19 enzyme and its core effect of reducing gastric acid secretion. These actions lead to specific regulatory restrictions for co-administration with other substances.

Official Interaction Statements

  • Co-administration with the antiviral Nelfinavir is formally contraindicated due to omeprazole significantly reducing nelfinavir's plasma exposure, which may lead to loss of therapeutic effect.
  • Omeprazole's CYP2C19 inhibition can prolong the elimination and increase the concentrations of co-administered CYP2C19 substrates such as Diazepam and Cilostazol, which may require monitoring.
  • The anti-platelet activity of Clopidogrel is diminished by co-administration, and use of this combination is advised to be avoided.
  • The reduction in gastric acid secretion interferes with the absorption of certain medicines that require an acidic pH for bioavailability, including Ketoconazole and Atazanavir.
  • Strong enzyme inducers, such as the antibiotic Rifampin and the herbal product St John’s Wort, may reduce the systemic concentration of omeprazole.
  • Long-term therapy may be associated with reduced absorption of Cyanocobalamin (Vitamin B12).

Interaction-Related Constraints

Constraint Affected Substance
Formal Contraindication Nelfinavir
Avoid Concomitant Use Clopidogrel, St John’s Wort, Rifampin
Procedural Stop Required Chromogranin A (CgA) testing (stop omeprazole 14 days prior)
Population-Specific Note Tacrolimus (cautions in CYP2C19 poor metabolizers)

Mechanism of Action

The Irreversible Blockade of the Proton Pump

Tamezol acts as a selective, irreversible inhibitor by targeting the H^+/ K^+ -ATPase enzyme, the Gastric Proton Pump found exclusively in the secretory membrane of the stomach's parietal cells. Omeprazole, a prodrug, is converted into its active form by the surrounding acid, allowing it to form a permanent covalent bond with the pump. This molecular interaction halts the final step of the gastric acid secretion pathway, directly blocking the transport of hydrogen ions ( H^+) into the stomach lumen.

Functional Suppression and Activity Dependence

The consequence of this permanent binding is a functional blockade of acid production that persists until the parietal cell synthesizes and inserts new, functional pumps, typically requiring 18 to 24 hours. Because the drug requires the acidic environment of an active pump for its activation, its mechanism is activity-dependent, meaning it primarily targets and inhibits pumps that are actively secreting acid. This inherent mechanistic constraint is the basis for the time required to establish maximum acid suppression, which results in the elevation of intragastric pH.

Dosage and Administration Information

Omeprazole is administered via two official routes: orally, using delayed-release (DR) capsules, tablets, or suspensions, or through intravenous (IV) infusion for clinical necessity. The standard oral regimen is once daily, and the medication is typically taken before a meal to optimize its action.

Standard adult dosing ranges vary widely based on the clinical usage pattern, but typically involve 20 mg to 40 mg once daily for short-term courses, such as those lasting 4 to 8 weeks for healing erosive esophagitis. For high-output conditions, like Zollinger-Ellison syndrome, doses may start at 60 mg once daily, with higher total daily doses being divided and administered twice daily.

A critical procedural instruction is the administration of the oral delayed-release form. To ensure the active ingredient is protected from stomach acid, capsules and tablets must be swallowed whole and must not be crushed or chewed. For patients unable to swallow, the capsule contents (enteric-coated pellets) may be mixed with certain non-carbonated, slightly acidic foods, like applesauce, and consumed immediately. Dosage adjustment is a standard procedure for specific populations, notably requiring a dose reduction (e.g., to 10 mg or 20 mg once daily) for patients with severe hepatic impairment. If a dose is missed, the standard protocol is to take it as soon as remembered unless it is close to the next scheduled dose, in which case the missed dose is skipped.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Key Research Findings

Research regarding Tamezol (Omeprazole) primarily involves randomized controlled trials (RCTs) and meta-analyses focused on its role as a proton pump inhibitor (PPI) for reducing gastric acid secretion. Studies have consistently examined Omeprazole’s efficacy and safety profile across its approved indications, generally comparing it against placebo or other agents in its class.


Omeprazole for Gastroesophageal Reflux Disease (GERD)

Omeprazole is a standard agent evaluated in the management of GERD. Clinical trials have investigated its ability to achieve symptomatic relief and esophageal healing in patients with erosive esophagitis. Research suggests that Omeprazole, when taken as prescribed, is frequently associated with significant acid suppression, which may lead to improvement in heartburn and regurgitation symptoms. Studies also examine its role in long-term maintenance therapy to prevent relapse of GERD symptoms.


Other Key Applications

Research has explored Omeprazole's use in other conditions related to gastric acid:

  • Peptic Ulcer Disease (PUD): Trials support Omeprazole's use in the healing of gastric and duodenal ulcers. It is often evaluated as part of multi-drug regimens for the eradication of Helicobacter pylori (H. pylori) infection, a primary cause of PUD.
  • Risk Reduction: Studies have also focused on its use for the prophylaxis (prevention) of nonsteroidal anti-inflammatory drug (NSAID)-associated gastric ulcers in at-risk patient populations.
  • Zollinger-Ellison Syndrome (ZES): Omeprazole is evaluated in the management of ZES, a rare condition causing excessive acid secretion, with research focused on high-dose regimens to control symptoms.

Key Studies & References

  1. Omeprazole for symptomatic relief in endoscopy negative reflux disease: a placebo controlled study

Frequently Asked Questions (FAQ)

Common questions about Tamezol (Omeprazole) (FAQ)

Q: How quickly does Tamezol start working after I take it?

According to regulatory documents, the initial effects of Tamezol begin relatively quickly. The drug's inhibitory effects on acid production typically start within one hour of administration, with the peak acid suppression effect being measured around two hours.

Q: How long do the effects of Tamezol typically last?

The acid-blocking effects of Tamezol last significantly longer than the drug itself stays in the bloodstream. Official product information indicates that the strong suppression of acid production lasts for approximately 24 hours, providing a sustained acid-reducing effect until the next scheduled administration.

Q: Does Tamezol have to be taken at a specific time of day?

Regulatory administration instructions advise taking the medication at the same time every day to maintain consistent acid suppression. The regulatory guidance advises that the drug is typically taken before a meal to optimize its intended action.

Q: If I miss a dose of Tamezol, what is the general recommendation about when to take it?

Regulatory guidance states that if a dose is missed, it should be taken as soon as it is remembered. However, if it is already close to the time for the next scheduled dose, the instruction is to skip the missed dose entirely.

Q: Can children or teenagers use Tamezol?

Official prescribing information confirms that Tamezol is established for use in adults and certain pediatric patients. Eligibility is governed by specific age thresholds—for instance, starting at age one year for symptomatic GERD and erosive esophagitis, as described in official labeling.

Q: What are the signs that Tamezol might be causing an unusual side effect?

Official safety warnings describe rare, serious adverse reactions that require professional guidance. These warnings relate to the rare possibility of severe allergic reactions (e.g., swelling, difficulty breathing) or symptoms linked to specific serious conditions, such as low magnesium or a rare kidney condition.

Q: Can I still take antacids when needed?

Regulatory information indicates that antacids can generally be taken with Tamezol if needed to relieve temporary symptoms of indigestion. They work differently by neutralizing existing stomach acid, while Tamezol works by preventing new acid production.

Q: Is Tamezol the same drug as Prilosec?

Omeprazole is the chemical name and active ingredient in Tamezol. Prilosec is one of the originally approved brand names for omeprazole delayed-release capsules or tablets.

Q: Why do official documents sometimes mention low vitamin B12 levels with Tamezol?

Official labeling notes that daily, long-term use, typically over three years, may be associated with reduced absorption or a deficiency of Cyanocobalamin (Vitamin B12). The absorption of Vitamin B12 relies on stomach acid, which the drug works to reduce.

Q: Can Tamezol cause headaches or dizziness?

Yes, regulatory documents list both headache and dizziness as possible adverse reactions. Headache is classified as a common adverse reaction, while dizziness is listed as an uncommon adverse reaction in the drug's official safety profile.

Q: Does taking Tamezol for a long time change how the body absorbs other things?

Yes, regulatory documents note that long-term daily use has been associated with reduced absorption of certain nutrients. This includes Vitamin B12 and minerals like magnesium.

Q: What should I do if Tamezol doesn't seem to be helping my condition?

Regulatory documents contain criteria for when to seek professional guidance, such as if symptoms continue or worsen after a specified period of use. Non-prescription use has a maximum duration of 14 days before professional guidance is required.

Q: Is it normal to feel a bit nauseous when first starting Tamezol?

Nausea and vomiting are listed in regulatory documents as common adverse reactions. This means they may affect up to 1 in 10 people taking the medicine.

Q: Does Tamezol contain any common allergens like gluten or dairy?

Regulatory descriptions of the inactive components list lactose as an ingredient in some formulations. Lactose is a component of milk, which may be relevant for individuals with certain sensitivities.

Q: Can Tamezol be taken on an empty stomach?

Regulatory administration instructions state to take the medicine before a meal to maximize its acid-blocking effect. This is typically instructed as taking it 30 to 60 minutes prior to eating.

Q: What happens in the body if I stop taking Tamezol suddenly?

Official safety information notes that stopping the medicine abruptly, especially after prolonged use, may be associated with increased acid production, which is sometimes described as a temporary increase in acid production.

Q: Is Tamezol used to treat H. pylori infections?

Yes, regulatory documents indicate that Tamezol is used in a specific therapeutic role. It is included as part of a multi-drug regimen, typically alongside antibiotics, for the eradication of H. pylori infection.

Q: How is the safety of Tamezol reviewed by agencies like the FDA or EMA?

The safety profile of the drug is assessed by regulatory authorities through surveillance and monitoring of adverse events. This process informs official updates to the drug's labeling.

Q: Does Tamezol affect liver function?

Tamezol is metabolized by the liver. Regulatory documents caution that patients with severe hepatic impairment (serious liver problems) may require special dose consideration.

Q: Are there different forms of Tamezol, like capsules or tablets?

Yes, Tamezol is available in multiple formulations, as described in official labeling. These forms include delayed-release capsules, delayed-release tablets, and powders for oral suspension.

Q: Is it true that Tamezol can affect magnesium levels?

Official safety warnings note that long-term daily use of the drug, typically longer than three months, has been associated with a risk of hypomagnesemia, which is low blood magnesium levels.

Q: Do any official sources mention a maximum time limit for using Tamezol?

Official labeling for the over-the-counter formulation states a maximum treatment duration of 14 days, with specific rules for repeated courses. The duration of treatment for prescription use is determined by the treating professional based on the specific condition.

Q: Why are some people concerned about stopping Tamezol after taking it daily?

This concern is based on the official safety observation that abrupt discontinuation of the drug, particularly after prolonged use, may be associated with increased acid production, sometimes described as a temporary increase in acid production.

Q: How long does the body take to clear Tamezol from the system?

Pharmacokinetic data indicates that the plasma half-life of omeprazole—which is how quickly the drug is cleared from the bloodstream—is short, typically between 0.5 and 1 hour.

Q: Are there specific warnings about Tamezol for people with kidney problems?

Regulatory documents note that dose adjustment for patients with renal (kidney) impairment is generally not necessary. However, warnings about the rare risk of acute interstitial nephritis, a kidney condition, are present in the safety information.

How should Tamezol be stored and disposed of?

How to Store and Dispose of Tamezol (Omeprazole)?

Official Storage Requirements

Regulatory documents mandate specific conditions for Omeprazole storage to maintain stability. The medicine must be stored at a temperature not exceeding 25 C or 30 C, depending on the formulation and national standard.

Protection Condition Requirement (Official Labeling)
Environmental Protect from light and moisture
Container Store in the original package and keep the container tightly closed
Child Safety Keep out of the sight and reach of children

For certain presentations in bottles, the in-use shelf life is limited to 100 days after first opening.

Disposal Instructions

Disposal of unused or expired Omeprazole must align with local regulatory requirements. Medicines should generally not be discarded via household wastewater. If a drug take-back program is unavailable, non-flushable medications should be prepared for disposal in household trash by mixing the drug with an undesirable substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tamezol found in:

A-Z Index: